PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “DERMATITIS, ATOPIC”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,207 records · Page 67Linked to original sources

Expression of a human SOCS protein, HSOCP-1, in peripheral blood eosinophils from patients with atopic dermatitis.

To identify new genes related to atopic dermatitis (AD), we screened for differentially expressed genes in peripheral blood eosinophils derived from AD patients and healthy volunteers. RNA was prepared from peripheral blood eosinophils obtained from both AD patients and healthy volunteers, and the expression of various genes was monitored using fluorescent differential display and real-time RT-PCR. One of the expressed sequence tags (ESTs) was expressed at a significantly higher level in AD patients than in healthy volunteers. A full-length cDNA was identified that encoded a human suppressor of cytokine signaling (SOCS) protein, HSOCP-1, also named hASB-8. The expression of HSOCP-1 was increased in cultured peripheral blood eosinophils after IL-4 stimulation, and overexpression of HSOCP-1 caused cell death in an eosinophil cell line, AML14.3D10. p34(SEI-1) was identified as a HSOCP-1-interacting protein by a yeast two-hybrid system. It is a protein that also interacts with the cyclin-dependent kinase inhibitor p16(INK4), suggesting that HSOCP-1 is involved in cell cycle control and apoptosis.

Apoptosis↗

Evidence for circulating complexes containing IgE in patients with atopic dermatitis.

18 out of 34 patients with atopic dermatitis were shown to have 5-32% of their serum IgE present in a high molecular weight (HMW) form (470,000 daltons). There was no simple correlation between the amount of HMW and the total serum IgE. The HMW peak was not affected by freezing and thawing the serum, but the complexes could be split by lowering the pH of serum fractionation. Some patients were tested sequentially on different occasions and although their clinical status may have altered during this time, there was no marked alteration of the HMW fraction. Results are compared with patients with raised IgE due to parasitic infections. Anti-IgE antibodies have been demonstrated in the HMW fraction.

Adult↗

In vitro generation of IFN-gamma in relationship to in vivo concentration of IgE and IgG subclasses and Fc epsilon Rl/CD23 positive circulating lymphocytes in patients with severe atopic dermatitis (AD).

In fifteen patients with severe atopic dermatitis (AD) and ten healthy controls we investigated the in vitro generation of IFN-gamma and analysed the number of Fc epsilon RL/CD23 (low affinity Fc receptor for IgE) positive lymphocytes. We found a significantly impaired capacity to secrete IFN-gamma after PHA-stimulation compared to controls in a significant proportion of patients. Serum IgG4 levels in patients were higher compared to controls. A significant portion of lymphocytes bearing the low affinity Fc receptor for IgE (CD23) was observed with the moab Tü1 in patients. Lymphocytes from healthy donors were completely negative or less than 2% positive for Tü1. Despite small numbers of patients a significant correlation was found between IFN-gamma generation in vitro and IgE serum concentration in patients, whereas the IFN-gamma generation and IgG4 concentration were negatively correlated in the patient group. The number of Fc epsilon RL/CD23 positive lymphocytes in patients was positive correlated with the serum IgG4 and IgE concentration and negative correlated with IFN-gamma generation in vitro. Our data suggest that a possible dysregulation of IFN-gamma, Interleukin 4 or other lymphokine production may be related to increased IgE and IgG4 production.

Adolescent↗

Are hyperlinear palms and dry skin signs of a concomitant autosomal ichthyosis vulgaris in atopic dermatitis?

In 30% to 40% of cases atopic dermatitis (AD) is believed to be associated with autosomal dominant ichthyosis vulgaris (ADI). The diagnosis of ADI can be proved by the ultrastructural demonstration of a defective keratohyalin (KH) synthesis, resulting in minute granules of crumbly appearance in only one layer of granular cells. To investigate the suggested frequent association of ADI with AD, ultrastructural examination of dry skin of 49 AD patients was performed. Only in 2 patients abnormal KH was demonstrated by electron microscopy. 17 patients, including the 2 patients with abnormal KH, showed hyperlinear palms. The present study shows that hyperlinear palms and dry skin are in most cases a phenotypic marker of AD alone and not a sign of concomitant ADI. A histologically one-layered or absent stratum granulosum may occur in the dry skin of patients with only AD and does not indicate a manifestation of concomitant ADI in all cases.

Adolescent↗

Food immediate-contact hypersensitivity (FICH) and elimination diet in young children with atopic dermatitis. Preliminary results in 107 children.

In atopic dermatitis [AD], not only food consumption, but direct skin-contact too can provoke hypersensitivity reactions. We imitated food immediate-contact hypersensitivity [FICH] to cow's milk, egg, peanut or soy by a skin provocation test. This skin application food test [SAFT] was applied in 91 patients aged up to 5 years and suffering from AD, and in 16 healthy controls (all SAFT-negative). In the SAFT-positive patients (n = 61), FICH to egg was observed in 72%, to cow's milk in 47%, to peanut in 34% and soy in only 1 patient. SAFT and RAST scores correlated weakly. Nevertheless, many discrepancies between SAFT and RAST results were found. In 20 of the 61 (33%) patients with FICH, a flare-up in AD was noted at SAFT testing. Upon introducing dietary restrictions, AD improved impressively in 9 of 23 patients who could be followed up. FICH is an important symptom in children with AD and food allergy.

Arachis↗

Patient education in the long-term management of atopic dermatitis.

Among the various forms of eczema, atopic dermatitis is the most common, distinctive, and difficult to manage. Educating patients about avoiding flare factors and proper use of moisturizers along with rational use of topical corticosteroids is crucial to effective long-term management. Openly reviewing facts and fallacies about allergies can help keep the focus on necessary skin care while dealing with patients' allergy concerns. The team approach of physician and nurse helps clarify confusing issues and maximizes patients' ability to effectively treat a chronic but controllable condition.

Anti-Inflammatory Agents↗

[The sauna in the treatment of children with atopic dermatitis].

Complex sauna therapy for children with atopic dermatitis gives positive clinical results and improves the condition of their autonomic nervous system. Marked clinical response but unsatisfied autonomic nervous system regulation necessitate long-term sauna treatment to cure this disease.

Adolescent↗

Management of severe atopic dermatitis with thymostimulin.

Two patients with severe atopic dermatitis unresponsive to conventional therapy were enrolled in a clinical trial on thymostimulin (TP-1). TP-1 was administered by subcutaneous injection 1 mg/kg/day for 14 days and then 1 mg/kg/day on alternate days for 2 months. Clinical and immunological status were evaluated at baseline and at regular intervals during the treatment. Clinical severity scores included eight skin conditions (erythema, edema, vesicle, crust, excoriation, scaling, lichenification, pigmentation), two subjective components (itchiness and loss of sleep), and extent of area affected. There was a statistically significant improvement in the overall assessment of the severity scores. There were no definite changes in immunological parameters including CD4, CD8 T-cell subpopulations and serum IgE, but eosinophil count showed a mark decrease in one case. No serious side effects were observed.

Adjuvants, Immunologic↗

Six food diet for childhood atopic dermatitis.

Sixty-three children with severe atopic dermatitis aged 0.4 to 14.8 years, were treated with a diet eliminating all but six foods for a 6-week period. Nine (14%) abandoned the diet before 6 weeks had elapsed. Twenty-one (33%) completed the diet but did not benefit. Thirty-three (52%) patients obtained greater than or equal to 20% improvement in the disease severity score at 6 weeks, and for these patients, foods were reintroduced singly at weekly intervals. The outcome at 12 months was the same for the group who responded to the diet, the group who failed to respond, and the group who failed to comply, because of the tendency for dermatitis to improve markedly in all three groups. Although dietary elimination of this type may be associated with immediate improvement, the long term outcome appears to be unaffected by dietary success or failure.

Adolescent↗

The effect of ultraviolet radiation with peaks at 300 nm and 350 nm in the treatment of atopic dermatitis.

Using a monochromator, 10 patients with atopic dermatitis were treated with 300 +/- 5 nm rays (UVB) and with 350 +/- 32 nm (UVAB) rays to compare the efficacy of these 2 wavebands. In each patient, 2 well-defined dermatitis patches were irradiated with 1 of the 2 wavelengths 5 d per week for 2 weeks. Each patch was subject to evaluation on 7 effect variables, the sum of which comprised the total score. The effect of these wavelengths on the 2 variables considered to be of greatest importance was subjected to statistical analysis. The UVAB light proved to be superior to the UVB light for both total score and overall evaluation score.

Adult↗

Osteomyelitis of the distal phalanges in three children with severe atopic dermatitis.

Three children with severe, secondarily infected atopic dermatitis since infancy developed osteomyelitis of the distal phalanges of the hands. The insidious onset of one or more distal subungual black macules was followed by edema, erythema, and pain in the involved fingers. No child had an elevated erythrocyte sedimentation rate or fever, but all had roentgenographic or scintigraphic evidence of bony destruction. In two children, Staphylococcus aureus grew from skin surface cultures; S aureus also grew from nail bed and osseous cultures of the distal phalanges; Streptococcus viridans grew from one child's nail bed. All children had prolonged hospitalizations. In two children, laboratory evaluation of immunologic function disclosed normal findings. We postulate that intense scratching of infected skin coupled with minor trauma to the fingertips created distal subungual microabscesses that spread contiguously to the underlying bone.

Bone and Bones↗

New therapeutic approaches in atopic dermatitis.

Novel approaches to the therapy for atopic dermatitis (AD) can now be considered because of recent advances in the pathogenesis of the disease. Several of these concepts are being tested in clinical trials. The effectiveness of cyclosporin A, plus reports of adoptive transfer of AD, or its clearing, following bone marrow transplantation, verify the criticalness of immune cells in AD pathogenesis. Thus, there is renewed interest in immunosuppressives, such as azathioprine and methotrexate, as well as new adhesion molecule and T-cell activation inhibitors. Therapy with the T-cell lymphokine, interferon-gamma, or the thymic hormone, thymopentin, is designed to inhibit the IL-4-dominated response of AD T-cells. This approach, rather than directly suppressing all immune responsiveness, represents a more specific targeting to improve the balance of a chronically disordered immune response. Recent findings of a therapeutic advantage of longer-wavelength phototherapy over UVB therapy may relate to specific immunologic events following UVB vs UVA photoinjury that are critical to the exacerbation of AD. Complex herbal mixtures used in traditional Chinese medicine are currently being evaluated, but toxicity and palatability may be limiting. Other dietary approaches, such as modifying the lipid balance, have generally not had much benefit. Because the safety and efficacy of the above treatments need further exploration, the physician must continue to utilize fundamental methods, such as mitigating trigger factors (i.e., microbes and stress, and certain foods in persons with documented sensitivity), on improving the abnormal epidermal lipid barrier to irritation, and on reducing cutaneous inflammation with mild topical steroids.

Clinical Trials as Topic↗

[Eye complications in atopic dermatitis].

Eye complications were studied in 240 cases of atopic dermatitis (age distribution 9 months to 40 years) hospitalized in the dermatology ward of our hospital. One hundred and thirty-four patients (55.8%) had at least one eye complication. Allergic conjunctivitis, cataracts, vernal conjunctivitis, retinal detachment, keratoconus, and retinal tears were detected in 28.3%, 17.9%, 2.1%, 1.3%, 1.3%, and 0.8%, respectively. Serum IgE levels and eye complications did not correlate. Routine ophthalmological examinations are recommended for patients with atopic dermatitis.

Adolescent↗

[Counseling of parents with children with atopic dermatitis].

Parents who have a child suffering from atopic dermatitis usually have to deal with a lot of problems. They seldom find support in coping with this problem. If families are left alone with these difficulties for a long period of time, chronical problems have to be expected, that might disturb the relationship between the parents and their child. A counseling program for parents of children suffering from atopic dermatitis is presented which was developed to prevent distress and helplessness of the parents. The program involved the following topics: 1. Medical information 2. Coping with scratching and itching 3. Care of the skin 4. Relaxation training. 5. Educational problems. Preliminary experiences with 23 parents indicate the usefulness of the counseling program as an important adjunct to the dermatological therapy of atopic eczema in childhood.

Adaptation, Psychological↗

Interferon-alpha therapy in atopic dermatitis.

Thirteen patients with a severe adult form of atopic dermatitis (AD) received 3.0 x 10(6) IU of recombinant interferon-alpha 2a (rIFN-alpha 2a) 3 times a week. A satisfactory response was obtained in 5 of them. Serum IgE levels in all 13 patients remained unchanged throughout the study. Flu-like symptoms were common, but clinical or laboratory adverse effects were otherwise slight. The moderately beneficial therapeutic effects observed in this study support a possible role for IFN-alpha in controlling immunologic deficiencies in atopic dermatitis.

Adolescent↗

Familial background of respiratory atopy. A factor of type I allergy to house dust mite in patients with atopic dermatitis.

Skin prick and radioallergosorbent tests with the house dust mite were performed in 120 patients with atopic dermatitis. The results showed that about 60% of the patients had type I allergy to the mite. Results of the prick and radioallergosorbent tests did not relate to the severity of skin involvement, nor to the seasonal fluctuation of the disease. Positive skin and radioallergosorbent tests occurred in many patients with atopic dermatitis who had a personal or family history of respiratory atopy. However, both of these tests were negative in the majority of patients with "pure" atopic dermatitis who had neither a personal nor a family history of respiratory atopy. It was suggested that a familial background of respiratory atopy is an important factor for the development of type I allergy to the house dust mite in patients with atopic dermatitis.

Adolescent↗